Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography

Table 3 Clinicopathologic features of the 15 patients who underwent a resection

Case	Cyst size (mm)	MPD diameter (mm)	MNs								Pathological diagnosis
			CT		EUS		CE-EUS		Pathology
			Presence	HCT (mm)	Presence	HEUS (mm)	Presence	HCE-EUS (mm)	Presence	HPath (mm)
1	36	12	+	23.4	+	25.2	+	22.2	+	21.2	IC
2	30	12	+	21.3	+	20.1	+	19.2	+	19.8	IC
3	40	12	+	13.9	+	19.1	+	17.6	+	17.2	IC
4	20	8	+	22.1	+	23.6	+	21.5	+	17.2	IC
5	50	2	+	18.9	+	15.2	+	14.3	+	13.1	IC
6	20	6	+	13.1	+	11.5	+	10.4	+	9.8	IC
7	30	9	+	14.4	+	10.6	+	9.5	+	9.3	IC
8	18	8	-	0	+	10.1	+	8.8	+	9.2	IC
9	38	6	-	0	+	10.9	+	9.7	+	9.1	IC
10	27	3	+	5.0	+	12.5	+	10.1	+	7.6	IC
11	25	13	+	11.3	+	13.8	+	10.3	+	10.1	HGD
12	30	6	+	6.4	+	10.1	+	8.5	+	7.3	HGD
13	30	6	-	0	+	10.5	+	8.4	+	5.3	HGD
14	31	12	-	0	+	2.3	+	2.3	+	2.1	HGD
15	28	3	-	0	+	3.9	+	2.7	-	0	ImGD

MPD: Main pancreatic duct; MNs: Mural nodules; CT: Computed tomography; EUS: Endoscopic ultrasonography; CE-EUS: Contrast-enhanced EUS; IC: Invasive carcinoma; HGD: High-grade dysplasia; ImGD: Intermediate-grade dysplasia; H_CT: MN height measured by CT; H_EUS: MN height measured by EUS; H_CE-EUS: MN height measured by CE-EUS; H_Path: MN height measured on pathological specimens.